Clinical Research Directory

Inclusion Criteria: * Participants eligible for inclusion in this investigation must meet all of the following criteria: 1. Voluntary written informed consent has been obtained from the participant or their legally authorized representative prior to any screening procedures. 2. Participant is at least 18 years of age, or of legal age of consent, at the time of signing the Informed Consent Form (ICF). 3. Participant has a clinical indication for cardiac pacing in accordance with the 2021 ESC Guidelines on Cardiac Pacing1. 4. Participant is willing and able to comply with all study requirements as specified in the study protocol. Exclusion Criteria: * Participants eligible for this Investigation must not meet any of the following criteria: 1. Subject implanted with an Aveir device on a non-permanent basis (e.g., CIED infection) 2. Subject is pregnant (if required by local law, women of child-bearing potential must undergo a pregnancy test within seven days prior to implant procedure) 3. Subject currently enrolled or planning to participate in a potentially confounding drug or device study during the study. 4. Subject meets any exclusion criteria required by local law (age or other). 5. Subject has life expectancy less than 12 months. 6. Subject is implanted with an electrically active implantable medical device with stimulation capabilities at risk to be impacted by the Aveir Link Module telemetry. 7. Subject has anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the study or to comply with the site standard follow-up visits, for example a mechanical tricuspid valve prosthesis or vein thrombosis, which could impede the delivery of implantable devices as planned by the implanters. 8. Subject is allergic/hypersensitive to \<1 mg dexamethasone sodium phosphate.